1. Chelate‐Thiolate‐Coordinate Ligands Modulating the Configuration and Electrochemical Property of Dinitrosyliron Complexes (DNICs). Issue 45 (25th September 2015) Authors: Yeh, Shih‐Wey; Lin, Chih‐Wei; Liu, Bai‐Heng; Tsou, Chih‐Chin; Tsai, Ming‐Li; Liaw, Wen‐Feng Journal: Chemistry Issue: Volume 21:Issue 45(2015) Page Start: 16035 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chelate‐Thiolate‐Coordinate Ligands Modulating the Configuration and Electrochemical Property of Dinitrosyliron Complexes (DNICs). Issue 45 (25th September 2015) Authors: Yeh, Shih‐Wey; Lin, Chih‐Wei; Liu, Bai‐Heng; Tsou, Chih‐Chin; Tsai, Ming‐Li; Liaw, Wen‐Feng Journal: Chemistry Issue: Volume 21:Issue 45(2015) Page Start: 16035 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cross‐entropy‐based joint carrier frequency offset estimation and multiuser detection for multicarrier code division multiple access systems. (6th December 2011) Authors: Lain, Jenn‐Kaie; Yang, Shang‐Yi; Lin, Chih‐Wei Journal: International journal of communication systems Issue: Volume 26:Number 8(2013:Aug.) Page Start: 964 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment. Issue 2 (10th April 2017) Authors: Poordad, Fred; Felizarta, Franco; Asatryan, Armen; Sulkowski, Mark S.; Reindollar, Robert W.; Landis, Charles S.; Gordon, Stuart C.; Flamm, Steven L.; Fried, Michael W.; Bernstein, David E.; Lin, Chih‐Wei; Liu, Ran; Lovell, Sandra S.; Ng, Teresa I.; Kort, Jens; Mensa, Federico J. Journal: Hepatology Issue: Volume 66:Issue 2(2017) Page Start: 389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial. Issue 2 (4th January 2018) Authors: Wyles, David; Poordad, Fred; Wang, Stanley; Alric, Laurent; Felizarta, Franco; Kwo, Paul Y.; Maliakkal, Benedict; Agarwal, Kosh; Hassanein, Tarek; Weilert, Frank; Lee, Samuel S.; Kort, Jens; Lovell, Sandra S.; Liu, Ran; Lin, Chih‐Wei; Pilot‐Matias, Tami; Krishnan, Preethi; Mensa, Federico J. Journal: Hepatology Issue: Volume 67:Issue 2(2018) Page Start: 514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure. Issue 4 (30th January 2018) Authors: Poordad, Fred; Pol, Stanislas; Asatryan, Armen; Buti, Maria; Shaw, David; Hézode, Christophe; Felizarta, Franco; Reindollar, Robert W.; Gordon, Stuart C.; Pianko, Stephen; Fried, Michael W.; Bernstein, David E.; Gallant, Joel; Lin, Chih‐Wei; Lei, Yang; Ng, Teresa I.; Krishnan, Preethi; Kopecky‐Br... Journal: Hepatology Issue: Volume 67:Issue 4(2018) Page Start: 1253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Good–Turing frequency estimation in a finite population. Issue 2 (12th November 2014) Authors: Hwang, Wen‐Han; Lin, Chih‐Wei; Shen, Tsung‐Jen Journal: Biometrical journal Issue: Volume 57:Issue 2(2015:Mar.) Page Start: 321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. High antiviral activity of NS5A inhibitor ABT‐530 with paritaprevir/ritonavir and ribavirin against hepatitis C virus genotype 3 infection. (3rd February 2016) Authors: Poordad, Fred; Landis, Charles S.; Asatryan, Armen; Jackson, Daniel F.; Ng, Teresa I.; Fu, Bo; Lin, Chih‐Wei; Yao, Betty; Kort, Jens Journal: Liver international Issue: Volume 36:Number 8(2016) Page Start: 1125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Integrated Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Taking Concomitant Proton Pump Inhibitors: 2017 Presidential Poster Award: 970. (October 2017) Authors: Flamm, Steven; Reddy, Rajender; Zadeikis, Neddie; Hassanein, Tarek; Bacon, Bruce; Maieron, Andreas; Zeuzem, Stefan; Bourliere, Marc; Calleja, Jose Luis; Oberoi, Rajneet; Lin, Chih‐Wei; Lovell, Sandra; Semizarov, Dimitri; Mensa, Federico Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study. Issue 2 (13th August 2019) Authors: Jonas, Maureen M.; Squires, Robert H.; Rhee, Susan M.; Lin, Chih‐Wei; Bessho, Kazuhiko; Feiterna‐Sperling, Cornelia; Hierro, Loreto; Kelly, Deirdre; Ling, Simon C.; Strokova, Tatiana; del Valle‐Segarra, Antonio; Lovell, Sandra; Liu, Wei; Ng, Teresa I.; Porcalla, Ariel; Gonzalez, Yuri Sanchez; Bur... Journal: Hepatology Issue: Volume 71:Issue 2(2020) Page Start: 456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗